Clayton Biotechnologies, Inc. works with biomedical companies to commercialize Clayton Foundation discoveries and innovations. Clayton Foundation technologies have been licensed to or are currently being developed by the companies listed below. We also license research tools to companies to help the development and creation of novel innovative products.
- Abbott
- Antech Diagnostics
- Aravasc, Inc.
- argenx
- Athena Diagnostics
- Avicin Therapeutics
- BioCad
- bluebird bio
- Focus Diagnostics
- Genzyme
- AbBC Therapies
- Idexx Laboratories
- Janssen
- Lilly
- Merck & Co., Inc.
- Molmed
- Neurocrine Biosciences
- Oxford Biomedica
- P&G
- Quest Diagnostics
- Renova Therapeutics
- SkyePharma
- Supergen
- Viacyte